MorphoSys
Biotechnology company focused on the research and development of fully human antibodies.
HQ location
Planegg, Germany
Website
Launch date
Employees
Enterprise value
$2.5b
Share price
$18.96 MOR
Company register number
HRB 121023 (München)
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
* | €2.7b Valuation: €2.7b | Acquisition | |
| Total Funding | 000k | ||
Atlas Venture(exited)
Max Planck Innovation(exited)
Max Planck Society(exited)
Genentech(exited)
Novartis(exited)
Third Rock Ventures(exited)
The Column Group(exited)
Venrock(exited)
| EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 357 % | (45 %) | 55 % | (14 %) | 6 % | 29 % | 31 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 39 % | (100 %) | 62 % | (41 %) | (67 %) | (31 %) | (13 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 30 % | (286 %) | (54 %) | (80 %) | (72 %) | (35 %) | (4 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 43 % | 125 % | 107 % | 119 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by MorphoSys
Edit
ACQUISITION by MorphoSys May 2015
ACQUISITION by MorphoSys Jun 2021
ACQUISITION by MorphoSys Oct 2010
ACQUISITION by Zoetis Sep 2023